Results 261 to 270 of about 9,561,546 (382)
Discriminating α-synuclein strains in Parkinson’s disease and multiple system atrophy
M. Shahnawaz +14 more
semanticscholar +1 more source
Single‐molecule fluorescence microscopy is combined with proteomic profiling to fingerprint the morphology and composition of TDP‐43 protein aggregates found in post‐mortem motor neuron disease brain tissues. Aggregate fingerprints can distinguish disease from control donors and detect unexpected TDP‐43 pathology in SOD1‐MND.
Dezerae Cox +9 more
wiley +1 more source
Metabolic Parkinson's disease. [PDF]
Invernizzi F +8 more
europepmc +1 more source
Action tremor in Parkinson's disease. [PDF]
H. Teräväinen, D. B. Calne
openalex +1 more source
In temporal lobe epilepsy, hippocampal APOE is markedly upregulated predominantly in microglia. APOE overexpression in microglia drives TLR4 and cGAS/STING‐dependent neuroinflammation, engages bidirectional crosstalk with neurons and astrocytes, increases neuronal excitability, and perturbs hippocampal lipid metabolism. These findings suggest that APOE‐
Jianwei Shi +10 more
wiley +1 more source
Glymphatic dysfunction as a potential driver of cerebral iron deposition in Parkinson's disease. [PDF]
Chen K +9 more
europepmc +1 more source
Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease.
P. Limousin +6 more
semanticscholar +1 more source
Identifying Tipping Points during Healthy Brain Aging through Single‐Nucleus Transcriptomic Analysis
This study applies single‐nucleus transcriptomics and systems dynamics to uncover nonlinear aging patterns in healthy human brains. By introducing dynamic network biomarker theory, the authors identify a critical tipping point at ages 56–60 during aging, and highlight glial instability as a key mediator.
Peiru Wu +9 more
wiley +1 more source
Determining Medication Adherence in Patients Treated for Parkinson's Disease and Related Factors. [PDF]
Besharatpour M +3 more
europepmc +1 more source
Visual fatigue and visual evoked potentials in multiple sclerosis, glaucoma, ocular hypertension and Parkinson's disease. [PDF]
D. Regan, David R. Neima
openalex +1 more source

